These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2085981)

  • 1. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity.
    Bergan T
    Infection; 1990; 18 Suppl 2():S65-9. PubMed ID: 2286464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal.
    Borgia M; Longo A; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
    Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients.
    Janknegt R; Hooymans PM; Fabius GT; Nohlmans-Paulssen MK; Machielsen C; Boogaard-van den Born J; Rang J; Smits CA; Willems-Thissen ME; Krommenhoek A
    Pharm World Sci; 1994 Jun; 16(3):149-53. PubMed ID: 7920366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of fosfomycin and its bioavailability.
    Cadórniga R; Diaz Fierros M; Olay T
    Chemotherapy; 1977; 23 Suppl 1():159-74. PubMed ID: 832511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
    Kuemmerle HP; Murakawa T; De Santis F
    Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin trometamol: activity in vitro against urinary tract pathogens.
    Greenwood D
    Infection; 1990; 18 Suppl 2():S60-4. PubMed ID: 2286463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.
    Bergogne-Bérézin E; Muller-Serieys C; Joly-Guillou ML; Dronne N
    Eur Urol; 1987; 13 Suppl 1():64-8. PubMed ID: 3569381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of fosfomycin trometamol (Monuril).
    Segre G; Bianchi E; Cataldi A; Zannini G
    Eur Urol; 1987; 13 Suppl 1():56-63. PubMed ID: 3569380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults.
    Borsa F; Leroy A; Fillastre JP; Godin M; Moulin B
    Antimicrob Agents Chemother; 1988 Jun; 32(6):938-41. PubMed ID: 3415215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin trometamol: historical background and clinical development.
    Gialdroni Grassi G
    Infection; 1990; 18 Suppl 2():S57-9. PubMed ID: 2286462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput colorimetric-based bioassay method for determination of fosmidomycin in plasma and urine and application for pharmacokinetic study.
    Cheoymang A; Na-Bangchang K
    J Pharmacol Toxicol Methods; 2010; 61(3):346-50. PubMed ID: 20188200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency].
    Fillastre JP; Leroy A; Josse S; Moulin B
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of fosfomycin.
    Kirby WM
    Chemotherapy; 1977; 23 Suppl 1():141-51. PubMed ID: 832510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic.
    Murakawa T; Sakamoto H; Fukada S; Konishi T; Nishida M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):224-30. PubMed ID: 7073262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.